Morebio Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 1

Morebio General Information

Description

Operator of a biotechnology firm intended to advance the development and production of peptide-based therapeutics through genetic engineering and modern peptide technologies. The company offers a full-spectrum peptide drug R&D infrastructure, including GMP-compliant manufacturing platforms and proprietary expression systems, enabling pharmaceutical companies and research institutions to access high-quality peptide drugs and biologics with enhanced precision and scalability.

Contact Information

Website
www.more-bio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • East District, 2nd Floor, Building B6, Guanggu Biocity
  • No. 666 Gaoxin Avenue, East Lake High-tech Zone
  • Wuhan, Hubei 430075
  • China
+86 027
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • East District, 2nd Floor, Building B6, Guanggu Biocity
  • No. 666 Gaoxin Avenue, East Lake High-tech Zone
  • Wuhan, Hubei 430075
  • China
+86 027

Morebio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Morebio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 20-Mar-2025 Completed Generating Revenue
3. Later Stage VC 01-Dec-2023 Completed Generating Revenue
2. Secondary Transaction - Private 13-Apr-2016 Completed
1. Early Stage VC 18-Feb-2011 Completed Generating Revenue
To view Morebio’s complete valuation and funding history, request access »

Morebio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Morebio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jinlan Investment Growth/Expansion Minority
To view Morebio’s complete investors history, request access »

Ready to get started?

Request a free trial

Morebio FAQs

  • When was Morebio founded?

    Morebio was founded in 2008.

  • Where is Morebio headquartered?

    Morebio is headquartered in Wuhan, China.

  • What is the size of Morebio?

    Morebio has 19 total employees.

  • What industry is Morebio in?

    Morebio’s primary industry is Drug Discovery.

  • Is Morebio a private or public company?

    Morebio is a Private company.

  • What is Morebio’s current revenue?

    The current revenue for Morebio is .

  • How much funding has Morebio raised over time?

    Morebio has raised $16.7M.

  • Who are Morebio’s investors?

    Jinlan Investment has invested in Morebio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process